Also, examination of cytokine profile (IL-6, IFN-γ, IL-10, TGF-β) and HCC-associated antigen-reactive lymphocyte populations could be performed to obtain more information to optimize the treatment formula. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.